Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-279846
Filing Date
2023-11-17
Accepted
2023-11-17 16:44:03
Documents
4
Effectiveness Date
2023-11-17

Document Format Files

Seq Description Document Type Size
1 S-8 POS d599420ds8pos.htm S-8 POS 54077
2 EX-5.1 d599420dex51.htm EX-5.1 10952
3 EX-23.2 d599420dex232.htm EX-23.2 2012
4 GRAPHIC g599420g1117003341370.jpg GRAPHIC 2476
  Complete submission text file 0001193125-23-279846.txt   71849
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-264943 | Film No.: 231419449
SIC: 2834 Pharmaceutical Preparations